Related Experiment Videos

Use of gentamicin to prevent intestinal side effects of lincomycin therapy

International Journal of Clinical Pharmacology and Biopharmacy
|November 1, 1978
PubMed

Insights

Adding gentamicin to lincomycin therapy prevented diarrhea in patients. This approach maintained healthy gut flora by inhibiting the growth of harmful bacteria, unlike lincomycin alone.

Area of Science:

  • Microbiology
  • Pharmacology
  • Gastroenterology

Background:

  • Lincomycin and clindamycin therapy can cause persistent diarrhea and colitis.
  • This is potentially due to alterations in gut microbiota, leading to an overgrowth of resistant bacteria like coliforms.

Purpose of the Study:

  • To investigate if co-administering gentamicin could prevent lincomycin-associated intestinal issues.

Main Methods:

  • A study involving human subjects was conducted.
  • Subjects received either lincomycin alone or lincomycin with oral gentamicin.
  • Bacteriological examinations of intestinal flora were performed.

Main Results:

  • Diarrhea occurred in 36.6% of subjects treated with lincomycin alone (11 out of 30).
  • None of the subjects treated with both lincomycin and gentamicin developed diarrhea (0 out of 18).
  • Lincomycin alone allowed potentially pathogenic bacteria (coliforms, clostridia) to persist, while gentamicin inhibited their growth.

Conclusions:

  • Simultaneous administration of gentamicin effectively prevents lincomycin-induced diarrhea.
  • Gentamicin helps maintain a balanced gut flora by suppressing harmful bacteria, thus preserving host resistance.

Related Concept Videos